Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Trinity Biotech plc Announces 33% Increase In Dividend To 20 Cents


Thursday, 25 Apr 2013 08:34am EDT 

Trinity Biotech plc announced that it is proposing a dividend of 20 cents per ADR, representing an increase of 33% on the dividend paid in fiscal 2012. The payment of this dividend is subject to shareholder approval, which will be sought at the Company's forthcoming AGM to be held on May 24, 2013. Subject to this approval being granted, the record date will be June 10, 2013 and payment will follow approximately 3 weeks later. 

Company Quote

17.49
-0.31 -1.74%
19 Dec 2014